Joanna Popiolek-Kalisz/LinkedIn
Oct 17, 2026, 02:31
Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention
Joanna Popiolek-Kalisz, Associate Professor and Head of the Department of Clinical Dietetics at Medical University of Lublin, Consulant in Cardiology at Grupa CenterMed and Magnoliowa Non-Public Healthcare Facility, shared a post on LinkedIn:
“CV Prevention and Intervention was a great fusion of two areas of cardiology that do not often mix!
It was of course also an opportunity to meet my great friends and colleagues who made this event so exceptional.
Thank you for the invitation to talk about novel pharmacotherapy of hypertension as the team.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?
-
Oct 17, 2026, 01:54Jim Hoffman: The Importance of Self-Advocacy and Understanding Autoimmune Mechanisms
-
Oct 17, 2026, 01:53Kristopher Jonas: Listening to Patients and Recognizing the Donors Who Make Treatment Possible
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang Miesbach։ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke